시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 감기약 시장 보고서(2025년)
Cold Remedies Global Market Report 2025
상품코드 : 1750946
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,625,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,576,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,527,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

감기약 시장 규모는 향후 수 년간 강력한 성장이 전망됩니다. 예측 기간 동안 예상되는 성장은 연구 개발에 대한 투자 증가, 예방 의료에 대한 인식 증가, 전체적인 건강 접근 방식의 증가, 소비자들의 건강 의식 증가, 그리고 정부의 지원 정책에 기인할 수 있습니다.

호흡기 감염의 이환율 증가는 향후 몇 년간의 감기 시장 성장을 이끌 것으로 예측됩니다. 이와 같은 감염의 급증은 유행과 관련된 장기간의 폐쇄에 따른 면역력의 저하나 사회적 거리의 축소에 의한 일반적인 바이러스에의 노출의 감소가 주된 원인이 되고 있습니다. 기침, 인후통 등의 증상을 완화하고 몸이 회복될 때까지 증상을 완화하는 중요한 역할을 합니다. 2023년 3월에 영국에 본사를 둔 정부 기관인 국가통계청은 영국에서 COVID-19 감염이 증가하여 인구의 약 2.66%가 양성 반응을 보였으며(40명 중 1명꼴), 병원 입원율이 10만 명당 10.62명으로 증가했다고 보고했습니다

감기약 시장의 주요 기업은 보다 안전하고 자연적인 대체품을 요구하는 소비자 수요 증가에 대응하기 위해 혁신적인 클린 라벨 제품의 개발에 주력하고 있습니다. 수수료, 방부제, 일반적인 알레르겐을 사용하지 않고 대신 천연 성분과 유기농 성분을 이용하여 효과적인 증상 완화를 가져오도록 처방되고 있습니다. Genexa Inc.는 Kids'Multi-Symptom Cold And Flu 및 Kids'Daytime Nighttime Cough Relief Value Pack 등, 클린 라벨의 새로운 아이용 기침 및 감기약을 발매했습니다.이 제제는 인공 색소, 파라벤, 감미료, 알레르겐을 배제해, 천연 베이스로서 유기 아가베 시럽을 배합하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 태와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Cold remedies are treatments designed to relieve symptoms of the common cold, including congestion, cough, and sore throat. These remedies may include medications, natural therapies, and supportive care, aiming to enhance comfort and promote recovery, though they do not cure the viral infection itself.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary drug types used in cold remedies include antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Antihistamines work by blocking histamine receptors to ease allergy-related symptoms such as sneezing, itching, and nasal congestion. Cold remedies come in various dosage forms, including oral syrups, tablets and pills, nasal drops, lozenges, and others. They are distributed through multiple channels such as hospital pharmacies, retail pharmacies, drug stores, supermarkets and hypermarkets, as well as e-commerce and online pharmacies.

The cold remedies market research report is one of a series of new reports from The Business Research Company that provides cold remedies market statistics, including the cold remedies industry global market size, regional shares, competitors with the cold remedies market share, detailed cold remedies market segments, market trends, and opportunities, and any further data you may need to thrive in the cold remedies industry. These cold remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cold remedies market size has grown strongly in recent years. It will grow from$9.31 billion in 2024 to $9.91 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth during the historic period can be attributed to the increasing prevalence of respiratory infections, a growing geriatric population, rising demand for effective combination products, an increased shift from prescription (Rx) to over-the-counter (OTC) medications, and heightened consumer demand for fast and effective symptom relief.

The cold remedies market size is expected to see strong growth in the next few years. It will grow to$12.64 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth projected for the forecast period can be attributed to increased investment in research and development, growing awareness of preventive healthcare, a rise in holistic health approaches, increasing health consciousness among consumers, and supportive government policies. Key trends expected during this period include the emergence of innovative solutions, technological advancements, novel product formulations, personalized medicine, and a shift toward tailored, immune-boosting solutions.

The increasing incidence of respiratory infections is anticipated to drive the growth of the cold remedies market in the coming years. Respiratory infections are illnesses that impact the respiratory system-such as the sinuses, throat, airways, and lungs-and are caused by viruses, bacteria, or other pathogens. A surge in these infections is largely attributed to weakened immune systems following prolonged pandemic-related lockdowns and reduced exposure to common viruses due to social distancing. Cold remedies play a crucial role in easing symptoms such as congestion, cough, and sore throat, offering symptomatic relief while the body recovers. For example, in March 2023, the Office for National Statistics, a UK-based government agency, reported that COVID-19 infections rose in England, with approximately 2.66% of the population testing positive (equivalent to 1 in 40 individuals), and hospital admissions increased to 10.62 per 100,000 people. Hence, the rising prevalence of respiratory infections is contributing to the expansion of the cold remedies market.

Key players in the cold remedies market are focusing on the development of innovative clean-label products to cater to rising consumer demand for safer, more natural alternatives. Clean cough and cold medicines are formulated without artificial dyes, sweeteners, preservatives, or common allergens, instead utilizing natural or organic ingredients to deliver effective symptom relief. For instance, in September 2023, Genexa Inc., a US-based healthcare company, launched new clean-label cough and cold medicines for children, including the Kids' Multi-Symptom Cold And Flu and the Kids' Daytime + Nighttime Cough Relief Value Pack. These formulations exclude artificial dyes, parabens, sweeteners, and allergens, and incorporate organic agave syrup as a natural base. They maintain the effectiveness of conventional medications while offering a non-toxic, clean alternative.

In February 2024, Cipla Limited, an India-based pharmaceutical firm, acquired Actor Pharma for $48.6 million. This acquisition is part of Cipla's strategy to enhance its over-the-counter (OTC) product lineup, broaden its consumer healthcare offerings, and solidify its footprint in the self-care and wellness space. Actor Pharma (Pty) Limited, based in South Africa, is known for manufacturing expectorants and contributes valuable expertise and product capabilities to Cipla's growing OTC portfolio.

Major players in the cold remedies market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Bayer AG, Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., Haleon plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Prestige Brands Holdings Inc., Weefsel Pharma Pvt. Ltd., Sunwin Healthcare Pvt. Ltd., AdvaCare Pharma USA, Centurion Remedies Private Limited, Himalaya Wellness Company, Genexa Inc., and Fibovil Pharmaceuticals Pvt. Ltd.

North America was the largest region in the cold remedies market in 2024. The regions covered in cold remedies report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cold remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cold remedies market consists of sales of inhalers, topical rubs, throat sprays, homeopathic remedies, and vitamin supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cold Remedies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cold remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cold remedies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cold remedies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Cold Remedies Market Characteristics

3. Cold Remedies Market Trends And Strategies

4. Cold Remedies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cold Remedies Growth Analysis And Strategic Analysis Framework

6. Cold Remedies Market Segmentation

7. Cold Remedies Market Regional And Country Analysis

8. Asia-Pacific Cold Remedies Market

9. China Cold Remedies Market

10. India Cold Remedies Market

11. Japan Cold Remedies Market

12. Australia Cold Remedies Market

13. Indonesia Cold Remedies Market

14. South Korea Cold Remedies Market

15. Western Europe Cold Remedies Market

16. UK Cold Remedies Market

17. Germany Cold Remedies Market

18. France Cold Remedies Market

19. Italy Cold Remedies Market

20. Spain Cold Remedies Market

21. Eastern Europe Cold Remedies Market

22. Russia Cold Remedies Market

23. North America Cold Remedies Market

24. USA Cold Remedies Market

25. Canada Cold Remedies Market

26. South America Cold Remedies Market

27. Brazil Cold Remedies Market

28. Middle East Cold Remedies Market

29. Africa Cold Remedies Market

30. Cold Remedies Market Competitive Landscape And Company Profiles

31. Cold Remedies Market Other Major And Innovative Companies

32. Global Cold Remedies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold Remedies Market

34. Recent Developments In The Cold Remedies Market

35. Cold Remedies Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기